Results of COMMANDER HF and MARINER studies with rivaroxaban published

Studies in very sick patient populations reaffirm and further strengthen the safety profile of rivaroxaban ...

Assistance for flood victims in India

Company makes available EUR 100,000 in immediate assistance for people impacted by the severe flooding in Kerala state, India ...

Bayer submits European marketing authorization application for larotrectinib for the treatment of TRK fusion cancer

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Launch first expected in Germany ...

Decision by Hamburg Regional Court in respect of reporting by WirtschaftsWoche

Bayer rejects WirtschaftsWoche report on Dicamba lawsuits

Bayer: Conditions for beginning Monsanto integration fulfilled

Legal remedies against jury verdict in California announced ...

Bayer and Haplogen collaborate to develop new treatments against pulmonary diseases

Bayer announces acceptance of nine abstracts on the use of Xarelto® in patients from a broad range of clinical and real-world studies

New COMPASS data about bleeding and cancer risk in patients with vascular disease ...

Bayer showcases Root2Success for healthy soils and roots